Coordinated ButaNexT (Next Generation Bio-butanol) and participated in BIOFOREVER, both focused on bio-based chemical production from lignocellulosic feedstocks.
BIOCLEAVE LIMITED
UK biotech SME developing biobutanol from lignocellulosic biomass via ABE fermentation for drop-in renewable fuel applications.
Their core work
Biocleave is a UK-based SME specializing in biobutanol production from lignocellulosic (non-food) biomass using the Acetone-Butanol-Ethanol (ABE) fermentation process. Their work spans the full biorefinery value chain — from biomass pre-treatment and enzymatic hydrolysis to fermentation optimization and in-situ product recovery. They develop bio-based fuel alternatives compatible with existing gasoline and diesel engines, positioning biobutanol as a drop-in renewable fuel. Their participation in both demonstration-scale and fundamental research projects suggests they bridge the gap between lab science and industrial application.
What they specialise in
ButaNexT and BIOFOREVER both involve processing forestry and agricultural residues into valuable bio-based products.
ButaNexT keywords explicitly reference enzymes, microorganisms, and fermentation optimization as core project activities.
Participated in CLOSPORE, studying Clostridium spore biology — the same genus used in ABE fermentation, suggesting deep microbial expertise.
How they've shifted over time
With all three projects starting within a single year (2015-2016), Biocleave's H2020 portfolio represents a concentrated burst of activity rather than a long evolution. Their keyword data is entirely concentrated in the latter half of their participation, centered on biobutanol and lignocellulosic conversion. The CLOSPORE project (fundamental Clostridium research) combined with ButaNexT (applied biobutanol demo) suggests they were simultaneously deepening their microbial science base while pushing toward industrial demonstration — a classic dual-track strategy for a technology SME.
Biocleave was moving from fundamental microbiology toward industrial-scale biorefinery demonstration, though their H2020 activity ceased after 2016 starts — potential partners should verify current status.
How they like to work
Biocleave operates as both a consortium leader and an active partner. They coordinated ButaNexT (their largest project at €731K) while participating in two other consortia, showing comfort in both leadership and contributory roles. With 44 unique partners across 11 countries from just 3 projects, they engage in large, diverse consortia — typical for bioeconomy demonstration projects that require expertise across the full value chain.
Despite being a small company with only 3 projects, Biocleave built a network of 44 partners spanning 11 countries, indicating involvement in large European bioeconomy consortia. Their geographic reach is broad for an SME of this size, reflecting the multi-partner nature of BBI demonstration projects.
What sets them apart
Biocleave combines deep Clostridium microbiology expertise with applied biobutanol process engineering — a rare pairing in a single SME. Their coordination of a BBI demonstration project (ButaNexT) shows they can lead industrial-scale biorefinery work, not just contribute lab results. For consortium builders in the bioeconomy space, they offer an SME that understands both the science (fermentation, enzymes) and the engineering (pre-treatment, in-situ product recovery, engine compatibility).
Highlights from their portfolio
- ButaNexTBiocleave's flagship as coordinator — a BBI demonstration project for next-generation biobutanol with €731K EC funding, their largest grant.
- BIOFOREVERLarge-scale BBI demonstration of bio-based products from forestry residues, showing Biocleave's role in European biorefinery scale-up efforts.
- CLOSPOREFundamental research on Clostridium spores — reveals the deep microbial science underpinning their applied biobutanol work.